MyMyelomaTeam

Both MGUS and Waldenström's macroglobulinemia (WM) involve abnormal plasma cells that produce M protein, but they differ in important ways.

MGUS is a non-cancerous condition where abnormal plasma cells produce small amounts of M protein. It rarely causes symptoms and is monitored rather than treated. There is a small Show Full Answer

Both MGUS and Waldenström's macroglobulinemia (WM) involve abnormal plasma cells that produce M protein, but they differ in important ways.

MGUS is a non-cancerous condition where abnormal plasma cells produce small amounts of M protein. It rarely causes symptoms and is monitored rather than treated. There is a small chance (about 1% per year) it could progress to myeloma.

Waldenström's macroglobulinemia is an actual cancer, specifically involving a type of cell called lymphoplasmacytoid lymphoma cells. It is more serious than MGUS and requires active treatment. Here are some key differences:

- Cell type: MGUS involves abnormal plasma cells; WM involves lymphoplasmacytoid lymphoma cells
- Cancer status: MGUS is non-cancerous; WM is a cancer
- Symptoms: MGUS rarely causes symptoms; WM can cause more significant health issues
- Treatment: MGUS typically requires monitoring only; WM requires active treatment, often with a drug called rituximab combined with other medications

A key genetic difference is that about 90% of WM cases carry a specific gene mutation (MYD88 L265P), which is rarely seen in myeloma-related conditions. This helps doctors tell them apart.

It's always worth discussing these distinctions with your specialist to understand how they relate to your specific situation.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

MGUS vs. Multiple Myeloma: What’s the Difference? (VIDEO)

MGUS and Peripheral Neuropathy